Webinar: Corning® Matribot® Bioprinter for Organoid Assays

Watch Webinar

This webinar demonstrates the use of the Corning Matribot Bioprinter to accurately and consistently dispense pancreatic cancer organoids for drug testing. Dispensed organoid cultures were assessed for toxicity to several chemotherapeutics that are traditionally used for treating pancreatic cancer. This data demonstrates an automated way to screen for the best drug choice for an individual’s pancreatic cancer.

Thank You

Thank you for your interest in our webinar. Click the link below to watch. 

A link to the webinar will also be sent to the email address you submitted on the form.

Watch Now